Stay updated on Nivolumab in Resectable NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.
Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. The new revision is now displayed in place of the previous version.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedLocations section added with Maryland, New York, Washington, and Quebec sites; the older location blocks were removed and the page revision updated to v3.3.3.SummaryDifference0.4%
- Check44 days agoChange DetectedTimestamp-related fields such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-17, 2025-11) were updated. No changes were made to the study content, arms, or eligibility criteria.SummaryDifference0.2%
- Check58 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Updated the revision tags to v3.3.2 and v3.2.0 in the Publications sections.SummaryDifference0.1%
- Check65 days agoChange DetectedRemoved the banner notice about a lapse in government funding from the page; the study details and supporting information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check80 days agoChange DetectedNo significant changes detected between the two screenshots; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.